Start app

Actuate Therapeutics

ACTU · Biotechnology

Verified executive transcripts, quotes, and interview insights from Actuate Therapeutics leadership.

1
Executives Tracked
Search Actuate Therapeutics Data API Access
Dan Schmitt
Dan Schmitt
President and Chief Executive Officer
5 appearances

About Actuate Therapeutics

Clinical-stage company developing elraglusib, a GSK-3 beta inhibitor, for cancer. [BIOTECH-2026-10-04]

Access All Actuate Therapeutics Executive Data

Search transcripts, quotes, and verified statements from every Actuate Therapeutics executive via our platform or API.

Start Free Trial View Pricing